Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-2006 | 09-2006 | 07-2006 | 06-2006 | 04-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 776 | -14,807 | 506 | -11,000 | 583 |
| Depreciation Amortization | 479 | 256 | 340 | 126 | 187 |
| Accounts receivable | -820 | -183 | -420 | -93 | -1,154 |
| Accounts payable and accrued liabilities | -503 | 1,505 | -418 | 937 | -103 |
| Other Working Capital | -551 | 2,361 | -2 | 1,851 | -1,165 |
| Other Operating Activity | 1,351 | 1,540 | 838 | 1,860 | 1,244 |
| Operating Cash Flow | $732 | $-9,328 | $844 | $-6,319 | $-408 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -14,481 | N/A | -18,884 | N/A |
| PPE Investments | -150 | -1,266 | -151 | -1,233 | -11 |
| Sale Of Investment | N/A | 12,548 | N/A | 12,548 | N/A |
| Purchase Sale Intangibles | N/A | -47 | N/A | -36 | N/A |
| Other Investing Activity | 0 | -47 | 0 | -36 | 0 |
| Investing Cash Flow | $-150 | $-3,246 | $-151 | $-7,605 | $-11 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 36 |
| Debt Repayment | -172 | N/A | -115 | N/A | -57 |
| Common Stock Issued | N/A | 13,265 | N/A | 12,652 | N/A |
| Common Stock Repurchased | -2,467 | N/A | -2,467 | N/A | -2,467 |
| Financing Cash Flow | $-2,639 | $13,265 | $-2,582 | $12,652 | $-2,488 |
| Beginning Cash Position | 3,106 | 3,827 | 3,106 | 3,827 | 3,106 |
| End Cash Position | 1,049 | 4,518 | 1,217 | 2,555 | 199 |
| Net Cash Flow | $-2,057 | $691 | $-1,889 | $-1,272 | $-2,907 |
| Free Cash Flow | |||||
| Operating Cash Flow | 732 | -9,328 | 844 | -6,319 | -408 |
| Capital Expenditure | -208 | -1,266 | -209 | -1,233 | -69 |
| Free Cash Flow | 524 | -10,594 | 635 | -7,552 | -477 |